Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ffp104 (2 trials)
Crohn Disease (Phase 2)
Fibrosis (Phase 2)
Liver Cirrhosis (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Trials (2 total)
Trial APIs (1 total)